Correction : Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results

• George A. Diaz,
• Roberto Giugliani,
• Nathalie Gufon,
• Simon A. Jones,
• Eugen Mengel,
• Maurizio Scarpa,
• Peter Witters,
• Abhimanyu Yarramaneni,
• Jing Li,
• Nicole M. Armstrong,
• Yong Kim,
• Catherine Ortemann-Renon,
• Monica Kumar

Affiliations

George A. Diaz

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai

Roberto Giugliani

Medical Genetics Service HCPA, Department of Genetics UFRGS, DASA and Casa Dos Raros

Nathalie Gufon

Reference Centre of Inherited Metabolic Disease in Femme Mère Enfant Hospital, Hospices Civils of Lyon

Simon A. Jones

Manchester University National Health Service Trust, St Mary’s Hospital

Eugen Mengel

Institute of Clinical Science for Lysosomal Storage Disorders, SphinCS GmbH

Maurizio Scarpa

University Hospital of Udine

Peter Witters

University Hospitals Leuven

Abhimanyu Yarramaneni

Sanofi

Jing Li

Sanofi

Nicole M. Armstrong

Sanofi

Yong Kim

Sanofi

Catherine Ortemann-Renon

Sanofi

Monica Kumar

Sanofi